Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study

Summary

To validate on the mid-term in moderate and severe renal failure (CKD 3-4) a nomogram to adapt a fixed metformin daily posology according to renal function on the basis of the first short-term study made by the investigators.

Timeline

Start

2016-03-16

Primary completion

2017-06-07

Completion

2017-06-07

Outcome

Outcome not reported

Stopped: “Investigator choice”

Drugs

Indications